Time for $5 graphics

Cepheid's price gouging for lifesaving test

Cepheid, it's time for $5

Tuberculosis - The world's deadliest infectious disease

Danaher! Cepheid! Don't fail this test! Drop the Price! $5 for ALL GeneXpert tests

Read, watch, share

Newsletter cover image

Newsletter |

05 September 2026

When policy impacts people

Decontamination teams are visiting the home of a patient who is being treated at the Elikya Ebola treatment centre. She has tested positive for the Bundibugyo virus.

Photo Credit: Julien Dewarichet/MSF

Press release |

01 September 2026

Ebola Research and development

Democratic Republic of the Congo

Treatment and prevention research on Bundibugyo virus disease must deliver for children, not leave them behind

3 min

WHO Executive Board's Special Session on Ebola

UN Photo/Christopher Black

Statement |

28 August 2026

Pandemic preparedness

Africa

76th session of the WHO Regional Committee for Africa

1 min

Newsletter cover image

Newsletter |

09 August 2026

Going analogue: benefits of analogue insulins for diabetes treatment and care

Medical staff providing treatment in MSF-supported Bolomba Ebola treatment center, Equateur province, DRC, August 2020

Photo credit: Franck Ngonga/MSF

Ebola: the diagnostic blind spot

Newsletter cover image

Newsletter |

12 July 2026

Test: have you heard about tests?

Report Cover Image

Issue brief |

07 July 2026

Diabetes

Kenya

MSF proposal for Kenya’s Social Health Authority (SHA) benefits package to include analogue insulin pens to improve care for people living with diabetes

A close-up of Siwar holding her insulin pen. Siwar has type 1 diabetes and received her insulin pen from the MSF clinic in Arsal. Drawing on Siwar's experience, her father explains to how insulin pens make life easier for diabetic kids.

Photo Credit: Carmen Yahchouchi/MSF

Press release |

07 July 2026

Diabetes

MSF calls for inclusion of analogue insulin pens to the Kenyan Social Health Authority benefits package

4 min